Other OTC - Delayed Quote USD

MediPharm Labs Corp. (MEDIF)

0.0630 +0.0033 (+5.55%)
At close: April 26 at 2:23 PM EDT

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. David A. Pidduck CEO & Director 502.49k -- --
Mr. Keith Strachan Co-Founder & President 470.38k -- --
Mr. Greg Hunter Chief Financial Officer 574.71k -- --
Mr. Patrick McCutcheon Founder 628.26k -- --
Mr. Saravan Subramaniam Vice President of Operations & Supply Chain -- -- --
Mr. Geoffrey Marr Executive VP & General Counsel -- -- --
Mr. Brett Moon Vice President of Sales -- -- --
Mr. Kirk Binns Executive Vice President of Global Accounts -- -- --

MediPharm Labs Corp.

151 John Street
Barrie, ON L4N 2L1
Canada
705-719-7425 https://www.medipharmlabs.com
Sector: 
Healthcare
Full Time Employees: 
166

Description

MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products. In addition, the company offers cannabis related medical information and services; and medical cannabis clinic services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

Corporate Governance

MediPharm Labs Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Oct 04, 2018
    Dividend Date

Upcoming Events

Mar 27, 2024
MediPharm Labs Corp. Earnings Call

Related Tickers